Form 144: ALHC proposed sale of 51,379 RSU shares on 10/09/2025
Rhea-AI Filing Summary
Form 144 filing for proposed sale of $908,894.51 in common stock (51,379 shares) with an approximate sale date of 10/09/2025. The shares were acquired as Restricted Stock Units on 10/04/2025 and show 51,379 units to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on NASDAQ. The filing lists 198,031,417 shares outstanding, and records prior 10b5-1 sales by the same account totaling 62,000 shares during August 2025 for aggregate gross proceeds of $946,833.62 across three trades. Certain standard issuer identification fields (issuer name and SEC file number) are not populated in the visible text, so the filing cannot be tied to an issuer by name from this extract.
Positive
- Planned sale is disclosed publicly, supporting regulatory transparency
- Broker listed (Morgan Stanley Smith Barney LLC), indicating institutional execution
Negative
- Issuer name and SEC file number are not provided in the visible extract, limiting issuer identification
- Large insider sales year-to-date (62,000 shares sold in August 2025 plus 51,379 proposed) which may increase share supply
Insights
Insider plans to sell recently vested RSUs and has executed prior 10b5-1 sales this year.
The filing documents a proposed sale of 51,379 common shares acquired as Restricted Stock Units on 10/04/2025, with an expected sale value of $908,894.51 on 10/09/2025. Sales are routed through Morgan Stanley Smith Barney LLC on NASDAQ, indicating use of an institutional broker for an orderly disposition.
Prior 10b5-1 executions show systematic selling in August 2025 totaling 62,000 shares and gross proceeds of $946,833.62, which suggests continued vesting-driven or plan-driven liquidity rather than an isolated trade. Monitor the completion date 10/09/2025 and any subsequent filings for cumulative insider sales against outstanding share count of 198,031,417.